TargetMol

MDK83190

Product Code:
 
TAR-T1772
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T1772-5mg5mg£98.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1772-10mg10mg£114.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1772-1mL1 mL * 10 mM (in DMSO)£118.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1772-25mg25mg£160.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1772-50mg50mg£199.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1772-100mg100mg£302.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1772-200mg200mg£449.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Apoptosis Activator 2 is a potent apoptosis activator, induceing caspase-3 activation, PARP cleavage, and DNA fragmentation .
CAS:
79183-19-0
Formula:
C15H9Cl2NO2
Molecular Weight:
306.14
Pathway:
Proteases/Proteasome; Apoptosis
Purity:
0.9867
SMILES:
Clc1ccc(CN2C(=O)C(=O)c3ccccc23)cc1Cl
Target:
Apoptosis; Caspase

References

1. Nguyen JT, et al. Proc Natl Acad Sci U S A, 2003, 100(13), 7533-7538. 2. Alavian KN, et al. Neural Dev, 2009, 16(4), 11. 3. Farivar TN, et al. N Am J Med Sci, 2012, 4(11), 582-585. 4. Nguyen TV, et al. J Neuroendocrinol, 2010, 22(9), 12013-1022.